PatientsVille.com Logo

PatientsVille

Bendrofluazide Side Effects

Common Bendrofluazide Side Effects


The most commonly reported Bendrofluazide side effects (click to view or check a box to report):

Fall (4)
Hypotension (4)
Chest Pain (4)
Dehydration (3)
Diarrhoea (3)
Cerebrovascular Accident (3)
Haematemesis (3)
Dizziness (3)
Ear Congestion (3)
Nausea (3)
Staphylococcal Infection (2)
Sneezing (2)
Pyoderma Gangrenosum (2)
Sympathectomy (2)
Renal Tubular Acidosis (2)
Head Injury (2)
Hyponatraemia (2)
Epistaxis (2)
Gastrointestinal Haemorrhage (2)
Syncope (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Bendrofluazide Side Effects Reported to FDA

The following Bendrofluazide reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Bendrofluazide on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Product Substitution Issue, Impaired Driving Ability, Convulsion
This is a report of a 52-year-old male patient (weight: NA) from UNITED KINGDOM, suffering from the following symptoms/conditions: NA, who was treated with Bendrofluazide (dosage: NA, start time: NS), combined with:
  • Levetiracetam (1000 Mg (500 Mg, 2 In 1 D), Oral)
  • Candesartan
  • Oxcarbazepine
  • Amlodipine
and developed a serious reaction and side effect(s). The consumer presented with:
  • Product Substitution Issue
  • Impaired Driving Ability
  • Convulsion
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bendrofluazide treatment in male patients, resulting in product substitution issue side effect.

Convulsion, Product Substitution Issue
This report suggests a potential Bendrofluazide Convulsion, Product Substitution Issue side effect(s) that can have serious consequences. A 52-year-old male patient (weight: NA) from UNITED KINGDOM was diagnosed with the following symptoms/conditions: NA and used Bendrofluazide (dosage: NA) starting NS. Soon after starting Bendrofluazide the patient began experiencing various side effects, including:
  • Convulsion
  • Product Substitution Issue
Drugs used concurrently:
  • Amlodipine Besylate
  • Oxcarbazepine (750 Mg, Bid)
  • Candesartan Cilexetil
  • Levetiracetam (500 Mg, Bid)
Although Bendrofluazide demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as convulsion, may still occur.

Pain In Extremity, Dysuria
This Pain In Extremity, Dysuria problem was reported by a health professional from UNITED KINGDOM. A 87-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 01, 2006 this consumer started treatment with Bendrofluazide (dosage: NA). The following drugs were being taken at the same time:
  • Simvastatin
  • Indapamide
  • Aspirin
When commencing Bendrofluazide, the patient experienced the following unwanted symptoms/side effects:
  • Pain In Extremity
  • Dysuria
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pain in extremity, may become evident only after a product is in use by the general population.

Rectal Haemorrhage, Weight Decreased, Gastrointestinal Carcinoma
This is a report of a 70-year-old female patient (weight: NA) from UNITED KINGDOM. The patient developed the following symptoms/conditions: NA and was treated with Bendrofluazide (dosage: Unk) starting Dec 21, 2000. Concurrently used drugs:
  • Prazosin (Unk)
  • Sotalol (Unk)
  • Salbutamol (Unk)
  • Enalapril (Unk)
  • Simvastatin (Unk)
  • Somatropin Rdna (0.3 Mg, 1x/day)
  • Hydrocortisone (Unk)
Soon after that, the consumer experienced the following side effects:
  • Rectal Haemorrhage
  • Weight Decreased
  • Gastrointestinal Carcinoma
The patient was hospitalized. This opens a possibility that Bendrofluazide treatment could cause the above reactions, including rectal haemorrhage, and some female subjects may be more susceptible.


Vision Blurred
A 74-year-old female patient (weight: NA) from UNITED KINGDOM with the following symptoms/conditions: hypertension started Bendrofluazide Tablets treatment (dosage: NA) on Jan 01, 1998. Soon after starting Bendrofluazide Tablets treatment, the subject experienced various side effects, including:
  • Vision Blurred
Concurrently used drugs:
  • Calcichew D3
  • Candesartan
  • Fosamax
  • Aspirin
  • Levothyroxine Sodium
This finding indicates that some female patients could be more vulnerable to Bendrofluazide Tablets.

Pancreatitis Relapsing
A 61-year-old male patient from UNITED KINGDOM (weight: NA) experienced symptoms, such as: NA and was treated with Bendrofluazide(dosage: 2.5 Unk, 1x/day). The treatment was initiated on Jan 01, 2009. After that a consumer reported the following side effect(s):
  • Pancreatitis Relapsing
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Bendrofluazide efficacy:
  • Amitriptyline Hcl (100 (unk))
  • Insulin
  • Clopidogrel (75 Unk, 1x/day)
  • Tramadol Hydrochloride (Unk)
  • Enbrel (50 Mg, Weekly)


Chest Pain, Pneumonia, Hospitalisation, Lung Neoplasm Malignant
In this report, Bendrofluazide was administered for the following condition: hypertension,gastrointestinal disorder,rheumatoid arthritis.A female consumer from UNITED KINGDOM (weight: NA) started Bendrofluazide treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Chest Pain
  • Pneumonia
  • Hospitalisation
  • Lung Neoplasm Malignant
A possible interaction with other drugs could have contributed to this reaction:
  • Omeprazole
  • Methotrexate
  • Humira
  • Meloxicam
  • Methotrexate
  • Lisinopril
  • Omeprazole
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Bendrofluazide treatment could be related to the listed above side effect(s).

Myocardial Infarction
This is a report of the following Bendrofluazide side effect(s):
  • Myocardial Infarction
A male patient from NEW ZEALAND (weight: NA) presented with the following condition: NA and received a treatment with Bendrofluazide (dosage: Unk) starting: NS.The following concurrently used drugs could have generated interactions:
  • Metformin (Unk)
  • Amlodipine (Unk)
  • Simvastatin (Unk)
  • Varenicline Tartrate (0.5 Mg, 1x/day)
  • Aspirin (Unk)
  • Inhibace (Unk)
This report suggests that a Bendrofluazide treatment could be associated with the listed above side effect(s).

Diabetes Mellitus Inadequate Control, Hypothyroidism
This Bendrofluazide report was submitted by a male consumer from UNITED KINGDOM (weight: NA). The patient was diagnosed with: NA and Bendrofluazide was administered (dosage: NA) starting: Oct 14, 2011. The consumer developed a set of symptoms:
  • Diabetes Mellitus Inadequate Control
  • Hypothyroidism
Other drugs used simultaneously:
  • Lansoprazole
  • Symbicort
  • Singulair
  • Moxonidine
  • Aliskiren
  • Diltiazem Hcl
  • Candesartan Cilexetil
  • Symbicort (200/6 Mcg Two Puffs Twice A Day)
Those unexpected symptoms could be linked to a Bendrofluazide treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Pulmonary Fibrosis, Pneumocystis Jiroveci Infection, Interstitial Lung Disease
This is a report of a possible correlation between Bendrofluazide use and the following symptoms/side effect(s):
  • Pulmonary Fibrosis
  • Pneumocystis Jiroveci Infection
  • Interstitial Lung Disease
which could contribute to an assessment of Bendrofluazide risk profile.A 84-year-old male consumer from NEW ZEALAND (weight: NA) was suffering from NA and was treated with Bendrofluazide (dosage: NA) starting NS.Other concurrent medications:
  • Azathioprine
  • Vincristine (Approximately 1 Week After The First Dose Of Rituximab)
  • Rituximab
  • Levothyroxine Sodium
  • Prednisone Tab (Foe 2 Days)
  • Prednisone Tab (Resumed For The Next 3 Months)
  • Warfarin Sodium
  • Prednisone Tab (Dose Was Tapered)


Ear Congestion
A 56-year-old female patient from UNITED KINGDOM (weight: NA) presented with the following symptoms: hypertension and after a treatment with Bendrofluazide (dosage: Unk) experienced the following side effect(s):
  • Ear Congestion
The treatment was started on Sep 09, 2008. Bendrofluazide was used in combination with the following drugs:
  • Simvastatin
  • Simvastatin (Unk)
This report could alert potential Bendrofluazide consumers.

Ear Congestion
In this report, a 56-year-old female patient from UNITED STATES (weight: NA) was affected by a possible Bendrofluazide (bendroflumethiazide) side effect.The patient was diagnosed with NA. After a treatment with Bendrofluazide (bendroflumethiazide) (dosage: NA, start date: NS), the patient experienced the following side effect(s):
  • Ear Congestion
The following simultaneously used drugs could have led to this reaction:
  • Simvastatin ((40 Mg), Oral)
  • Simvastatin ((40 Mg), Oral)
The findings here stress that side effects should be taken into consideration when evaluating a Bendrofluazide (bendroflumethiazide) treatment.

Ear Congestion
This is a report of a 56-year-old female patient from UNITED KINGDOM (weight: NA), who used Bendrofluazide (dosage: NA) for a treatment of hypertension. After starting a treatment on Sep 09, 2008, the patient experienced the following side effect(s):
  • Ear Congestion
The following drugs could possibly have interacted with the Bendrofluazide treatment
  • Simvastatin
Taken together, these observations suggest that a Bendrofluazide treatment could be related to side effect(s), such as Ear Congestion.

Linear Iga Disease, Globulins Increased, Alanine Aminotransferase Increased
This linear iga disease side effect was reported by a health professional from . A 58-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Bendrofluazide (bendroflumethiazide) (dosage: NA), which was started on NS. Concurrently used drugs:
  • Amlodipine
When starting to take Bendrofluazide (bendroflumethiazide) the consumer reported the following symptoms:
  • Linear Iga Disease
  • Globulins Increased
  • Alanine Aminotransferase Increased
These side effects may potentially be related to Bendrofluazide (bendroflumethiazide).

Linear Iga Disease
This is a Bendrofluazide side effect report of a 58-year-old female patient (weight:NA) from UNITED KINGDOM, suffering from the following symptoms/conditions: NA, who was treated with Bendrofluazide (dosage:2.5 Mg, start time: NS), combined with:
  • Amlodipine Besylate
, and developed a serious reaction and a linear iga disease side effect. The patient presented with:
  • Linear Iga Disease
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Bendrofluazide treatment in female patients suffering from NA, resulting in linear iga disease.

Hypokalaemia, Hyponatraemia, Hyperammonaemia, Lethargy, Muscular Weakness, Coordination Abnormal, Hyperreflexia, Urinary Tract Infection Enterococcal, Vulvovaginal Discomfort
This report suggests a potential Bendrofluazide hypokalaemia side effect(s) that can have serious consequences. A 52-year-old female patient from UNITED KINGDOM (weight:NA) was diagnosed with the following health condition(s): NA and used Bendrofluazide (dosage: NA) starting NS. Soon after starting Bendrofluazide the patient began experiencing various side effects, including:
  • Hypokalaemia
  • Hyponatraemia
  • Hyperammonaemia
  • Lethargy
  • Muscular Weakness
  • Coordination Abnormal
  • Hyperreflexia
  • Urinary Tract Infection Enterococcal
  • Vulvovaginal Discomfort
Drugs used concurrently:
  • Lamotrigine
  • Carbamazepine (600 Mg)
  • Citalopram Hydrobromide
The patient was hospitalized. Although Bendrofluazide demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hypokalaemia, may still occur.

Herpes Zoster
This herpes zoster problem was reported by a health professional from UNITED KINGDOM. A 75-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Jan 27, 2010 a consumer started treatment with Bendrofluazide (dosage: NA). The following drugs/medications were being taken at the same time:
  • Remicade
  • Lansoprazole
  • Aspirin
  • Mycophenolate Mofetil
  • Hydroxyzine
  • Acetaminophen
When commencing Bendrofluazide, the patient experienced the following unwanted symptoms /side effects:
  • Herpes Zoster
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as herpes zoster, may become evident only after a product is in use by the general population.

Neutropenia, Diarrhoea
This is a Bendrofluazide side effect report of a male patient (weight: NA) from NEW ZEALAND. The patient developed the following symptoms/conditions: NA and was treated with Bendrofluazide (dosage: 2.5mg Per Day) starting Jan 01, 2007. Concurrently used drugs:
  • Thalidomide (100mg Per Day)
  • Metoprolol Tartrate (95mg Per Day)
  • Prednisone Tab
Soon after that, the consumer experienced the following of symptoms:
  • Neutropenia
  • Diarrhoea
The patient was hospitalized. This opens a possibility that Bendrofluazide could cause neutropenia and that some male patients may be more susceptible.

Pyoderma Gangrenosum, Staphylococcal Infection, Limb Injury, Skin Ulcer
A 81-year-old female patient (weight: NA) from UNITED KINGDOM with the following symptoms: hypertension,metastatic renal cell carcinoma started Bendrofluazide treatment (dosage: 2.5 Mg, Unk) on Feb 01, 2011. Soon after starting Bendrofluazide treatment, the consumer experienced several side effects, including:
  • Pyoderma Gangrenosum
  • Staphylococcal Infection
  • Limb Injury
  • Skin Ulcer
. Concurrently used drugs:
  • Sutent (37.5 Mg, 1x/day)
This finding indicates that some patients can be more vulnerable to developing Bendrofluazide side effects, such as pyoderma gangrenosum.

Pyoderma Gangrenosum, Staphylococcal Infection
This pyoderma gangrenosum side effect was reported by a health professional from UNITED KINGDOM. A 81-year-old female patient (weight:NA) experienced the following symptoms/conditions: hypertension,metastatic renal cell carcinoma.The patient was prescribed Bendrofluazide (dosage: 2.5 Mg, Unk), which was started on Feb 01, 2011. Concurrently used drugs:
  • Sutent (37.5 Mg, 1x/day)
.When starting to take Bendrofluazide the consumer reported symptoms, such as:
  • Pyoderma Gangrenosum
  • Staphylococcal Infection
These side effects may potentially be related to Bendrofluazide.

Blood Potassium Decreased, Hyponatraemia, Confusional State, Blood Cortisol Increased, Blood Creatinine Increased, Blood Osmolarity Decreased, Blood Urea Decreased
This is a report of a 91-year-old female patient (weight: NA) from UNITED KINGDOM, suffering from the following symptoms/conditions: cardiac failure congestive,urinary tract infection, who was treated with Bendrofluazide (dosage: 2.5 Mg, 1x/day, start time: Dec 29, 2010), combined with:
  • Trimethoprim (200 Mg, 2x/day)
  • Carvedilol (3.75 Mg, Unk)
  • Warfarin Sodium (Unk)
  • Ramipril (10 Mg, 1x/day)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Blood Potassium Decreased
  • Hyponatraemia
  • Confusional State
  • Blood Cortisol Increased
  • Blood Creatinine Increased
  • Blood Osmolarity Decreased
  • Blood Urea Decreased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bendrofluazide treatment in female patients, resulting in blood potassium decreased side effect. The patient was hospitalized.

Gastrointestinal Haemorrhage, Duodenal Ulcer, Gastric Ulcer, Haematemesis
This report suggests a potential Bendrofluazide Gastrointestinal Haemorrhage, Duodenal Ulcer, Gastric Ulcer, Haematemesis side effect(s) that can have serious consequences. A 65-year-old female patient (weight: NA) from UNITED KINGDOM was diagnosed with the following symptoms/conditions: hypertension,sciatica and used Bendrofluazide (dosage: 5 Mg, 1x/day) starting Feb 25, 2011. Soon after starting Bendrofluazide the patient began experiencing various side effects, including:
  • Gastrointestinal Haemorrhage
  • Duodenal Ulcer
  • Gastric Ulcer
  • Haematemesis
Drugs used concurrently:
  • Ibuprofen (400 Mg, 3x/day)
  • Amlodipine (15 Mg, 1x/day)
  • Acetaminophen And Codeine Phosphate (1 Df, 4x/day)
  • Naproxen (250 Mg, 3x/day)
The patient was hospitalized. Although Bendrofluazide demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as gastrointestinal haemorrhage, may still occur.

Amnesia, Alcohol Intolerance, Disorientation
This Amnesia, Alcohol Intolerance, Disorientation problem was reported by a health professional from UNITED KINGDOM. A 51-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 12, 2011 this consumer started treatment with Bendrofluazide (dosage: NA). The following drugs were being taken at the same time:
  • Omeprazole
  • Sertraline Hydrochloride
  • Vesicare (10 Mg, Uid/qd)
When commencing Bendrofluazide, the patient experienced the following unwanted symptoms/side effects:
  • Amnesia
  • Alcohol Intolerance
  • Disorientation
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as amnesia, may become evident only after a product is in use by the general population.

Angioedema
This is a report of a 53-year-old female patient (weight: NA) from UNITED KINGDOM. The patient developed the following symptoms/conditions: NA and was treated with Bendrofluazide (dosage: NA) starting Jun 01, 2010. Concurrently used drugs:
  • Cetirizine Hcl
  • Angitil
  • Cetirizine Hcl
  • Doxazosin Mesylate
  • Aliskiren
  • Aliskiren
  • Amlodipine
  • Bisoprolol
Soon after that, the consumer experienced the following side effects:
  • Angioedema
The patient was hospitalized. This opens a possibility that Bendrofluazide treatment could cause the above reactions, including angioedema, and some female subjects may be more susceptible.

Angioedema
A 53-year-old female patient (weight: NA) from UNITED KINGDOM with the following symptoms/conditions: NA started Bendrofluazide treatment (dosage: Unk) on Jun 01, 2010. Soon after starting Bendrofluazide treatment, the subject experienced various side effects, including:
  • Angioedema
Concurrently used drugs:
  • Doxazosin Mesylate (Unk)
  • Cetirizine Hcl (10 Mg, Qd)
  • Angitil (Unk)
  • Amlodipine (Unk)
  • Bisoprolol (Unk)
  • Aliskiren (300 Mg, Qd)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Bendrofluazide.

1 of 3 



Top 10 Bendrofluazide Side Effects for Women

Women Side EffectsReports
Ear Congestion 3
Fall 3
Hypotension 3
Angioedema 2
Bronchospasm 2
Cataract Operation 2
Chest Pain 2
Dehydration 2
Diarrhoea 2
Duodenal Ulcer 2

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Bendrofluazide Side Effects

    Did You Have a Bendrofluazide Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Bendrofluazide for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Bendrofluazide Safety Alerts, Active Ingredients, Usage Information

    More About Bendrofluazide

    Side Effects reported to FDA: 63

    Bendrofluazide safety alerts: No

    Reported deaths: 6

    Reported hospitalizations: 24

    Latest Bendrofluazide clinical trials